Diabetes Associated With Maternally Inherited Diabetes and Deafness (MIDD): From Pathogenic Variant to Phenotype
Diabetes · 01.02.2025 · 74 (2) · 153-163
DOI: 10.2337/db24-0515 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes, online erschienen am 18.11.2024. Verfasst von Jean-Pierre Chanoine und 2 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Diabetes Unit, Department of Pediatrics, BC Children's Hospital and The University of British Columbia, Vancouver, British Columbia…. Hauptthemen laut MEDLINE: Deafness, Mitochondrial Diseases, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Maternally inherited diabetes and deafness (MIDD) is a monogenic mitochondrial disorder caused by a pathogenic variant in the MT-TL1 gene encoding a leucine transfer RNA. We propose a new hypothesis that explains how the MT-TL1 variant causes impaired glucose tolerance and diabetes in MIDD. We suggest that diabetes in MIDD primarily depends on a variable combination of insulin resistance and impaired β-cell function that seems more likely to occur in the presence of high skeletal muscle heteroplasmy and moderate β-cell heteroplasmy for m.3243A>G. The underlying genetic defect generates oxidative stress and disrupts the tricarboxylic acid cycle, leading to mTORC1 hyperactivity and modifying mitochondrial retrograde signaling. mTORC1 hyperactivity contributes to insulin resistance and β-cell dysfunction and to an increased load of the m.3243A>G phenotypic variant. Abnormal mitochondrial signaling affects the nuclear epigenome and influences MIDD phenotype. We highlight evidence that, despite being an apparent pathogenic factor, heteroplasmy in the blood and in tissues does not fully explain the phenotypic variability of this condition and that other factors, including mtDNA copy number, additional nuclear or mitochondrial variants, environmental factors, and metabolic characteristics of the patient, may contribute. A better understanding of the mechanisms leading to MIDD will help inform novel management strategies for this form of diabetes. Article Highlights Maternally inherited diabetes and deafness (MIDD) is a mitochondrial disorder characterized primarily by hearing impairment and diabetes. m.3243A>G, the most common phenotypic variant, causes a complex rewiring of the cell with discontinuous remodeling of both mitochondrial and nuclear genome expressions. We propose that MIDD depends on a combination of insulin resistance and impaired β-cell function that occurs in the presence of high skeletal muscle heteroplasmy (approximately ≥60%) and more moderate cell heteroplasmy (∼25%–72%) for m.3243A>G. Understanding the complex mechanisms of MIDD is necessary to develop disease-specific management guidelines that are presently lacking.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Endocrinology and Diabetes Unit, Department of Pediatrics, BC Children's Hospital and The University of British Columbia, Vancouver, British Columbia, Canada.
- Division of Endocrinology, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Medical Genetics, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: Jean-Pierre Chanoine
Zitieren
APA
Chanoine, J. P., Thompson, D. M., & Lehman, A. (2025). Diabetes Associated With Maternally Inherited Diabetes and Deafness (MIDD): From Pathogenic Variant to Phenotype. Diabetes, 74(2), 153-163. https://doi.org/10.2337/db24-0515
Vancouver
Chanoine JP, Thompson DM, Lehman A. Diabetes Associated With Maternally Inherited Diabetes and Deafness (MIDD): From Pathogenic Variant to Phenotype. Diabetes. 2025;74(2):153-163. doi:10.2337/db24-0515
BibTeX
@article{Chanoine2025,
author = {Chanoine, Jean-Pierre and Thompson, David M and Lehman, Anna},
title = {Diabetes Associated With Maternally Inherited Diabetes and Deafness (MIDD): From Pathogenic Variant to Phenotype},
journal = {Diabetes},
year = {2025},
volume = {74},
number = {2},
pages = {153--163},
doi = {10.2337/db24-0515}
}
EUVIMED